Search | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Persistent elevation of plasma thrombopoietin levels after treatment in severe aplastic anemia

    ... dynamic change over time after treatment. We examined plasma concentrations of hematopoietic growth factors sequentially in 55 ... noted between TPO levels and platelet counts. The increased plasma TPO levels could be required to maintain normal platelet counts in ...

    Research Article last updated 10/23/2017 - 11:19am.

  2. Persistent elevation of plasma thrombopoietin levels after treatment in severe aplastic anemia

    ... dynamic change over time post treatment. We examined plasma concentrations of hematopoietic growth factors sequentially in 55 ... noted between TPO levels and platelet counts. The increased plasma TPO levels could be required to maintain normal platelet counts in ...

    Research Article last updated 10/02/2017 - 9:40am.

  3. Specific Plasma Autoantibody Reactivity in Myelodysplastic Syndromes

    ... Increased autoantibody reactivity in plasma from Myelodysplastic Syndromes (MDS) patients may provide ... study we investigated Immunoglobulin G reactivity in plasma from MDS, Acute Myeloid Leukemia post MDS patients, and a healthy ...

    Research Article last updated 11/26/2013 - 12:27pm.

  4. A plasma microRNA signature as a biomarker for acquired aplastic anemia

    ... monitor the disease. We analyzed circulating miRNAs in plasma samples of aplastic anemia patients in order to identify ... miRNAs. A total of 179 miRNAs were analyzed in 35 plasma samples from 13 aplastic anemia, 11 myelodysplastic syndrome, and 11 healthy controls using the Serum/Plasma Focus microRNA PCR Panel. Subsequently, 19 miRNAs from the discovery set ...

    Research Article last updated 10/06/2016 - 9:39am.

  5. Plasma circulating-microRNA profiles are useful for assessing prognosis in patients with cytogenetically normal myelodysplastic syndromes

    ... systems. The goal of this study is to identify plasma microRNAs useful for classification and risk stratification of ... technology (NanoString) to profile microRNA expression in plasma samples of 72 patients with myelodysplastic syndromes and 12 healthy ...

    Research Article last updated 09/24/2014 - 10:41am.

  6. Decreased plasma cytokines associate with low platelet counts in aplastic anemia and immune thrombocytopenic purpura

    ... Background: We previously found plasma levels of CD40 ligand (CD40L), chemokine (C-X-C motif) ligand 5 ... platelets. Patients/Methods: We measured cytokines in the plasma of immune thrombocytopenic purpura (ITP) and AA patients using the ...

    Research Article last updated 07/30/2012 - 1:53pm.

  7. Population pharmacokinetics of fludarabine in patients with aplastic anemia and Fanconi anemia undergoing allogeneic hematopoietic stem cell transplantation.

    ... NT5E gene (rs2295890 G>C) exhibited significantly lower plasma F-araA clearance compared to those with wild-type genotype (7.12 vs ... and multivariate analysis (P=0.02). The influence of plasma F-araA levels need to be evaluated in a larger cohort of patients to ...

    Research Article last updated 05/22/2017 - 10:32am.

  8. Blood Transfusions

    ... blood. These might be the red blood cells, platelets or plasma . Rarely is whole blood (red cells, plasma, platelets, and white cells) used for a transfusion. ...

    Topic section last updated 03/29/2016 - 7:17pm.

  9. Paroxysmal Nocturnal Hemoglobinuria (PNH)

    ... Blood consists of blood cells floating in plasma . Plasma is mostly made of water. It also includes salts, proteins, hormones, ...

    Page last updated 09/30/2017 - 11:34am.

  10. Efficacy, safety, and pharmacokinetics of subcutaneous azacitidine in Taiwanese patients with higher-risk myelodysplastic syndromes

    ... (N = 12) and North American (N = 45) patients. Maximum plasma concentration was higher in Taiwanese patients; however, mean ...

    Research Article last updated 02/03/2017 - 10:05am.